Skip to main content
TipRanks
Go Ultimate75% OFF

Bone Therapeutics (0R55) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Bone Therapeutics has a market cap or net worth of EUR 1.31M. The enterprise value is EUR 3.78M.

Market Cap
EUR 1.31M
Enterprise Value
EUR 3.78M

Share Statistics

Bone Therapeutics has 652,862,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
652,862,300
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Bone Therapeutics’s return on equity (ROE) is 1.26 and return on invested capital (ROIC) is -127.14%.

Return on Equity (ROE)
1.26
Return on Assets (ROA)
-3.01
Return on Invested Capital (ROIC)
-127.14%
Return on Capital Employed (ROCE)
1.12
Revenue Per Employee
45.25K
Profits Per Employee
-2.40M
Employee Count
12
Asset Turnover
0.06
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Bone Therapeutics is -5.65. Bone Therapeutics’s PEG ratio is 0.06.

PE Ratio
-5.65
PS Ratio
43.36
PB Ratio
3.27
Price to FCF
-6.02
Price to Operating Cash Flow
-6.04
PEG Ratio
0.06

Income Statement

In the last 12 months, Bone Therapeutics had revenue of 543.00K and earned -28.78M in profits. Earnings per share was -0.21.

Revenue
543.00K
Gross Profit
543.00K
Operating Income
-7.04M
Pretax Income
-29.03M
Net Income
-28.78M
EBITDA
-6.80M
Earnings Per Share (EPS)
-0.21

Cash Flow

In the last 12 months, operating cash flow was -2.37M and capital expenditures 12,000, giving a free cash flow of -1.95M billion.

Operating Cash Flow
-2.37M
Free Cash Flow
-1.95M
Free Cash Flow per Share
-0.02

Dividends & Yields

Bone Therapeutics pays an annual dividend of EUR 0.29, resulting in a dividend yield of ―

Dividend Per Share
EUR 0.29
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-16.60%
Earnings Yield
-17.70%

Stock Price Statistics

Beta
-0.01
52-Week Price Change
0.00%
50-Day Moving Average
0.01
200-Day Moving Average
0.01
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

Bone Therapeutics upcoming earnings date is Apr 29, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 28, 2026
Next Earnings Date
Apr 29, 2027
Ex-Dividend Date
Mar 15, 2022

Financial Position

Bone Therapeutics as a current ratio of 0.12, with Debt / Equity ratio of -122.91%

Current Ratio
0.12
Quick Ratio
0.12
Debt to Market Cap
3.27
Net Debt to EBITDA
-4.13
Interest Coverage Ratio
-1.18

Taxes

In the past 12 months, Bone Therapeutics has paid -7,000 in taxes.

Income Tax
-7,000
Effective Tax Rate
0.00

Enterprise Valuation

Bone Therapeutics EV to EBITDA ratio is -13.52, with an EV/FCF ratio of -15.94.

EV to Sales
114.74
EV to EBITDA
-13.52
EV to Free Cash Flow
-15.94
EV to Operating Cash Flow
-15.98

Balance Sheet

Bone Therapeutics has EUR 816.00K in cash and marketable securities with EUR 26.79M in debt, giving a net cash position of -EUR 25.98M billion.

Cash & Marketable Securities
EUR 816.00K
Total Debt
EUR 26.79M
Net Cash
-EUR 25.98M
Net Cash Per Share
-EUR 0.04
Tangible Book Value Per Share
-EUR 0.12

Margins

Gross margin is 77.44%, with operating margin of -871.43%, and net profit margin of -767.29%.

Gross Margin
77.44%
Operating Margin
-871.43%
Pretax Margin
-1146.24%
Net Profit Margin
-767.29%
EBITDA Margin
-848.87%
EBIT Margin
-871.43%